Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Sold by Mirova US LLC

Mirova US LLC cut its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 3.0% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 370,096 shares of the medical equipment provider’s stock after selling 11,590 shares during the period. Intuitive Surgical makes up 2.3% of Mirova US LLC’s holdings, making the stock its 20th largest position. Mirova US LLC owned approximately 0.10% of Intuitive Surgical worth $193,175,000 at the end of the most recent quarter.

Other hedge funds have also modified their holdings of the company. Atala Financial Inc acquired a new position in shares of Intuitive Surgical in the fourth quarter valued at about $25,000. Berbice Capital Management LLC acquired a new stake in Intuitive Surgical during the fourth quarter worth about $26,000. BankPlus Trust Department acquired a new stake in Intuitive Surgical during the fourth quarter worth about $28,000. Kohmann Bosshard Financial Services LLC acquired a new stake in Intuitive Surgical during the fourth quarter worth about $31,000. Finally, MidAtlantic Capital Management Inc. acquired a new stake in Intuitive Surgical during the third quarter worth about $33,000. 83.64% of the stock is owned by institutional investors and hedge funds.

Intuitive Surgical Price Performance

NASDAQ ISRG opened at $488.80 on Tuesday. The company has a market cap of $174.10 billion, a PE ratio of 76.26, a price-to-earnings-growth ratio of 5.85 and a beta of 1.43. The stock’s 50 day simple moving average is $566.38 and its 200-day simple moving average is $531.96. Intuitive Surgical, Inc. has a 1-year low of $364.17 and a 1-year high of $616.00.

Analyst Ratings Changes

ISRG has been the topic of several analyst reports. Stifel Nicolaus raised their target price on Intuitive Surgical from $525.00 to $610.00 and gave the stock a “buy” rating in a report on Thursday, December 5th. CICC Research initiated coverage on Intuitive Surgical in a report on Monday, January 27th. They set a “neutral” rating and a $550.00 target price on the stock. Wells Fargo & Company raised their target price on Intuitive Surgical from $630.00 to $687.00 and gave the stock an “overweight” rating in a report on Friday, January 24th. Royal Bank of Canada raised their target price on Intuitive Surgical from $611.00 to $641.00 in a report on Monday, January 27th. Finally, JPMorgan Chase & Co. raised their target price on Intuitive Surgical from $575.00 to $675.00 and gave the stock an “overweight” rating in a report on Friday, January 24th. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating and sixteen have assigned a buy rating to the company’s stock. According to MarketBeat.com, Intuitive Surgical presently has an average rating of “Moderate Buy” and a consensus price target of $610.19.

Insider Buying and Selling

In related news, EVP Myriam Curet sold 408 shares of Intuitive Surgical stock in a transaction that occurred on Tuesday, February 11th. The stock was sold at an average price of $589.75, for a total transaction of $240,618.00. Following the transaction, the executive vice president now owns 353 shares in the company, valued at approximately $208,181.75. This trade represents a 53.61 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, CFO Jamie Samath sold 94 shares of the firm’s stock in a transaction on Wednesday, January 29th. The stock was sold at an average price of $571.11, for a total value of $53,684.34. Following the sale, the chief financial officer now directly owns 2,630 shares of the company’s stock, valued at approximately $1,502,019.30. This trade represents a 3.45 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 33,754 shares of company stock worth $17,691,621. 0.90% of the stock is owned by corporate insiders.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.